To Study the Oral Bioavailability of a New Combination Formation of Decitabine and Tetrahydrouridine in Healthy Males
Clinical trial NCT05816356 · COMPLETED
Trial details
- NCT number
- NCT05816356
- Sponsor
- EpiDestiny, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-24
- Primary completion
- 2023-06-30
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.